WealthPLAN Partners’s iShares US Medical Devices ETF IHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-4,350
Closed -$253K 363
2021
Q1
$253K Buy
4,350
+276
+7% +$15.3K 0.02% 289
2020
Q4
$229K Sell
4,074
-2,184
-35% -$114K 0.02% 300
2020
Q3
$332K Buy
6,258
+444
+8% +$21.5K 0.03% 237
2020
Q2
$286K Buy
5,814
+732
+14% +$31.3K 0.03% 251
2020
Q1
$218K Buy
+5,082
New +$214K 0.03% 226
2016
Q3
$5.91K Sell
246
-246
-50% -$5.85K ﹤0.01% 686
2016
Q2
$5.56K Buy
+492
New +$10.7K ﹤0.01% 1946

Other funds holding IHI

WealthPLAN Partners's IHI Position: Q2 2021 in Review

WealthPLAN Partners sold out of iShares US Medical Devices ETF (IHI) in Q2 2021, closing a stake of 4,350 shares — an estimated $253K sold.

WealthPLAN Partners first reported a position in IHI in Q2 2016 and held it in 7 quarters. The position peaked at $332K in Q3 2020. 559 funds tracked by Wall St. Rank hold IHI as of Q2 2021.

  • WealthPLAN Partners reported no remaining iShares US Medical Devices ETF position as of Q2 2021 after selling out during the quarter.
  • WealthPLAN Partners sold 4,350 iShares US Medical Devices ETF shares in Q2 2021, an estimated $253K.
  • WealthPLAN Partners first reported a position in iShares US Medical Devices ETF in Q2 2016 and held it in 7 quarters.
  • WealthPLAN Partners's iShares US Medical Devices ETF position peaked at $332K in Q3 2020.
  • 559 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2021.

Based on WealthPLAN Partners's 13F filing for Q2 2021, filed 19 Aug 2021.